UP!
| 2016-04-01 | Reiterated Rating | HC Wainwright | Buy | $3.50 |
| 2015-09-01 | Initiated Coverage | HC Wainwright | Buy | $3.50 |
| 2015-08-13 | Lower Price Target | HC Wainwright | Buy | $5.00 to $3.50 |
| 2015-03-31 | Lower Price Target | HC Wainwright | Buy | $9.00 to $5.00 |
| 2014-12-22 | Set Price Target | HC Wainwright | Buy | $9.00 |
| 2014-06-02 | Initiated Coverage | Laidlaw | Buy | $8.00 |
| 2014-05-05 | Initiated Coverage | HC Wainwright | Buy | $9.00 |
| 1970-01-01 |
| 2016-04-01 | Reiterated Rating | HC Wainwright | Buy | $3.50 |
| 2015-09-01 | Initiated Coverage | HC Wainwright | Buy | $3.50 |
| 2015-08-13 | Lower Price Target | HC Wainwright | Buy | $5.00 to $3.50 |
| 2015-03-31 | Lower Price Target | HC Wainwright | Buy | $9.00 to $5.00 |
| 2014-12-22 | Set Price Target | HC Wainwright | Buy | $9.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In RXII 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Galena Biopharma, Inc. | 201.16% (32393095) | GALE / RXII / |
| Advanced RNA Technologies, LLC | 7.59% (1221723) | RXII / |
| Eliseev Alexey Chief Business Officer | 5.90% (950312) | RXII / |
| CAUWENBERGH GEERT President & CEO | 0.89% (142583) | DARA / RXII / |
| Bitterman Robert J | 0.27% (44000) | RXII / |
| Dorman H. Paul | 0.23% (37500) | RXII / |
| Pavco Pamela Chief Development Officer | 0.11% (17173) | GALE / RXII / |
| Lockshin Curtis | 0.08% (13000) | RXII / SRNE / |
| Dispersyn Gerrit Chief Development Officer | 0.02% (3500) | RXII / |
UM